Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015819 | 0.93 | MEN1 (0.33) | MEN1LMNAKMT2ADPP4HTT | |
| SCHEMBL10047272 | 0.86 | MEN1 (0.33) | MEN1LMNAKMT2A | |
| SCHEMBL15368172 | 0.80 | — | — | |
| SCHEMBL10047069 | 0.79 | — | — | |
| SCHEMBL1742782 | 0.77 | DPP4 (0.33) | MEN1LMNAKMT2ADPP4HTT | |
| SCHEMBL8365 | 0.72 | — | — | |
| SCHEMBL8531420 | 0.72 | MEN1 (0.60) | MEN1LMNAKMT2A | |
| SCHEMBL45629 | 0.72 | — | — | |
| SCHEMBL14518604 | 0.71 | HTT (0.35) | DPP4HTT | |
| Deanol SCHEMBL10476577 | 0.71 | MEN1 (0.50) | MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680338-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2014-03-25 | — | — | US | disclosed |
| US-8680338-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2014-03-25 | — | — | US | disclosed |
| US-8680338-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2014-03-25 | — | — | US | disclosed |
| EP-2468714-B1 | Polyamino polyalcohol derivatives | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-02-26 | — | — | EP | disclosed |
| US-20140020601-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2014-01-23 | — | — | US | disclosed |
| US-20140020601-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2014-01-23 | — | — | US | disclosed |
| US-20140020601-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2014-01-23 | — | — | US | disclosed |
| US-8575396-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575396-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575396-B2 | Low-VOC polyamino alcohols | ANGUS CHEMICAL COMPANY (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120165521-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2012-06-28 | — | — | US | disclosed |
| US-20120165521-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2012-06-28 | — | — | US | disclosed |
| US-20120165521-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADVANCION CORPORATION | 2012-06-28 | — | — | US | disclosed |
| EP-2468714-A1 | Method for prepararing polyamino polyalcohol derivatives | Dow Global Technologies LLC (US) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468714-A1 | Method for prepararing polyamino polyalcohol derivatives | Dow Global Technologies LLC (US) | 2012-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165521-A1 | LOW-VOC POLYAMINO ALCOHOLS | ADH1A, ADH1C, ADH5 | MEN1 4285/4885LMNA 2096/4885KMT2A 853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.